Teladoc Health, Inc. Common Stock (TDOC)
$10.99
0.19 (1.70%)
TDOC Stock Quote Delayed 30 Minutes
Teladoc Health Is a Cathie Wood Stock That You Need Now
TDOC stock is under selling pressure, but fast-growing revenue and a team-up with an e-commerce giant should put Teladoc back on track.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
1.80B
PE Ratio
-1.90
EPS
-5.77
Volume (Avg. Vol.)
11.30M
Day's Range
$10.80 - $11.55
52-Week Range
$6.76 - $15.95
Dividend & Yield
N/A (N/A)
TDOC Stock Predictions, Articles, and Teladoc Health, Inc. Common Stock News
The Bears Were Right When They Sold Teladoc Months Ago
TDOC stock isn't going to rise for long even if investors get suckered in by earnings and the idea that revenue growth is "strong."
Feeling Bold? Check Out Teladoc Health While It’s Still Oversold
The telemedicine market is poised for substantial growth, and Teladoc's revenues are robust. So maybe, TDOC stock is finally ready to run.
Teladoc Stock Is an Attractive Long-Term Buy at Current Levels
TDOC stock is poised to grow from emerging opportunities in the industry. Its large client base and geographical reach works in its favor.
Teladoc Stock Is Due for a Major Upside Reversal
Teladoc is worth at least $110 a share assuming its revenue grows at historical rates for the next few years.
After a Rough Year, It’s Time to Reconsider Investing in Teladoc Health
TDOC stock has been out of favor for a while, but Teladoc's business model is evolving and virtual care is still a high-conviction market.
Teladoc Stock Is Returning to Long-Term Pivotal Zones
Demand for Teladoc services is will remain healthy far past the pandemic. Therefore, TDOC stock will find buyers in the long term.
A New Year Won’t Fix Teladoc’s Long-Term Prognosis
Teladoc is losing tons of money and TDOC stock isn't cheap on other metrics. As such, shares are a clear "avoid" for the time being.
Don’t Give Up On Teladoc Health Yet, Give It One More Shot
Teladoc Health is still a global leader in whole-person virtual care, yet TDOC stock remains grossly undervalued and ready for a breakout.
Teladoc Health’s Stock Is Likely To Be Revived
Can shares of Teladoc Health be resuscitated? The Purchase, Harrison, New York-based company that facilitates telemedicine (virtual visits between doctors and patients) has seen its share price fall 55% this year to $88.81 as enthusiasm for healthcare services delivered online fizzles.
7 Stocks to Buy Now for a Potential Year-End Rally
Here are seven stocks to buy that should make great additions to a long-term portfolio before a potential year-end rally.
Teladoc Is Oversold and Undervalued With Positive Catalysts About to Kick in
TDOC stock is oversold and undervalued as it beats Q3 earnings. The company has made significant acquisitions, which could pay off in 2022.
MEME ETF: The Top 10 Holdings of the New Roundhill Fund for Meme Stock Investors
The new Roundhill MEME ETF (MEME) is live and with it comes an opportunity to invest in a wide variety of meme stocks it holds.
5 of Cathie Wood’s Biggest Losers to Watch as the ARKK ETF Plunges Today
All eyes are on the ARKK ETF as a majority of its growth holdings seem to be declining. Here are 5 losers that may warrant a second glance.
